CVR: 42093734
DKK 2,927,421
Gross profit
Net result: DKK -821,765
SPICA THERAPEUTICS
CVR · view ownership and management
Director registered: Geert Gilbert Tackaert
CVR · 30/10/2024
View the full event history
OncoSpear ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Niels Jonas Heilskov Graversen and Geert Gilbert Tackaert. The company is owned by SPICA THERAPEUTICS. In 2025, the company reported a gross profit of DKK 2,927,421 and a net result of DKK -821,765 compared with DKK -6,461,139 the year before. Equity in the 2025 report amounted to DKK 569,861.
Source: annual report 2025, Danish Business Authority
OncoSpear ApS is experiencing significant financial challenges, as evidenced by its declining gross profit and increasing losses over the years. In 2025, the company reported a gross profit of 2,927,421 DKK but still incurred a loss of 821,765 DKK, following a trend of escalating losses that peaked at -6,694,240 DKK in 2023. Equity has decreased from 7,852,765 DKK in 2023 to 569,861 DKK in 2025, indicating a concerning erosion of financial stability. The absence of revenue data raises questions about its market position and operational viability within the pharmaceutical manufacturing industry, suggesting a need for strategic adjustments to improve profitability and restore equity.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at udvikle, markedsføre, licensere og sælge lægemidler, herunder at udvikle en forskningsplatform, der vil blive brugt til at identificere receptorer, der kan binde til lægemiddelkandidater, samt dermed beslægtede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 2.9 mio. | -822 t. | 9.5 mio. | 570 t. | 5 | |
| 202401/01/2024 – 31/12/2024 | -4.7 mio. | -6.5 mio. | 3.3 mio. | 1.4 mio. | 5 | |
| 202301/01/2023 – 31/12/2023 | -5.4 mio. | -6.7 mio. | 9.3 mio. | 7.9 mio. | 5 | |
| 202201/01/2022 – 31/12/2022 | -640 t. | -1.1 mio. | 7.5 mio. | 7.1 mio. | 1 | |
| 202101/02/2021 – 31/12/2021 | -26 t. | -26 t. | 33 t. | 24 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningOncoSpear ApS was founded on 1 February 2021.
OncoSpear ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
OncoSpear ApS is owned by SPICA THERAPEUTICS.
In 2025, OncoSpear ApS reported a gross profit of DKK 2,927,421.
The management of OncoSpear ApS consists of Niels Jonas Heilskov Graversen and Geert Gilbert Tackaert.
OncoSpear ApS is located at c/o Anders Etzerodt, Lucernevej 2, 8382 Hinnerup.
Claim this page to add your logo and social links. Free to get started.
OncoSpear ApS has published its annual report for 2025. Gross profit came to DKK 2,927,421, and the net result was DKK -821,765.
Address changed to Lucernevej 2 2, 8382 Hinnerup (January 7, 2026).
OncoSpear ApS has published its annual report for 2024. Gross profit came to DKK -4,652,093, and the net result was DKK -6,461,139.
As of March 6, 2025, KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of OncoSpear ApS.
As of March 6, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of OncoSpear ApS.
As of October 30, 2024, Søren Kragh Moestrup has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Holger Jon Møller has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Anders Etzerodt has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Toby Lawrence has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Alexander Bharmal Demoulin has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Debora Catharina Dumont has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Geert Gilbert Tackaert is registered as director of OncoSpear ApS.
As of August 22, 2024, is registered as an owner of OncoSpear ApS with an ownership share of 100%.
OncoSpear ApS has published its annual report for 2023. Gross profit came to DKK -5,395,986, and the net result was DKK -6,694,240.
OncoSpear ApS has published its annual report for 2022. Gross profit came to DKK -639,949, and the net result was DKK -1,090,059.
As of June 27, 2023, Jens Kristian Damsgaard has left the board of directors of OncoSpear ApS.
As of June 22, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of OncoSpear ApS.
As of January 2, 2023, Søren Kragh Moestrup has joined the board of directors of OncoSpear ApS.
As of January 2, 2023, Debora Catharina Dumont has joined the board of directors of OncoSpear ApS.
As of January 1, 2023, Søren Kragh Moestrup has left the board of directors of OncoSpear ApS.
As of January 1, 2023, Debora Catharina Dumont has left the board of directors of OncoSpear ApS.
As of September 30, 2022, Alexander Bharmal Demoulin has joined the board of directors of OncoSpear ApS.
As of September 30, 2022, Debora Catharina Dumont has joined the board of directors of OncoSpear ApS.
OncoSpear ApS has published its annual report for 2021. Gross profit came to DKK -25,963, and the net result was DKK -26,170.
As of February 1, 2021, Jens Kristian Damsgaard has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Søren Kragh Moestrup has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Holger Jon Møller has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Anders Etzerodt has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Toby Lawrence has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Niels Jonas Heilskov Graversen is registered as director of OncoSpear ApS.
OncoSpear ApS was founded on February 1, 2021.
